A detailed history of Euclidean Technologies Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Euclidean Technologies Management, LLC holds 15,666 shares of VTRS stock, worth $181,725. This represents 0.14% of its overall portfolio holdings.

Number of Shares
15,666
Previous 15,666 -0.0%
Holding current value
$181,725
Previous $174,000 13.79%
% of portfolio
0.14%
Previous 0.17%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

BUY
$9.95 - $12.27 $155,876 - $192,221
15,666 New
15,666 $164,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Euclidean Technologies Management, LLC Portfolio

Follow Euclidean Technologies Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Euclidean Technologies Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Euclidean Technologies Management, LLC with notifications on news.